Date |
Company |
Amount |
Funding type |
Investors |
Therapeutic area |
Type of Information |
2017-06-06 |
CTI BioPharma (USA - WA) |
|
private placement |
|
Cancer - Oncology |
Private placement |
2017-06-01 |
Neurovive Pharmaceutical (Sweden) |
1 million SEK (€ 0.1 million) |
grant |
Vinnova, Swedish Governmental Agency for Innovation Systems (Sweden) |
Rare diseases - Genetic diseases |
Grant |
2017-06-01 |
Flashcell (France) |
€ 1.5 million |
financing round |
Auriga Partners (France) Vectalys (France) |
|
Financing round |
2017-05-31 |
Achaogen (USA - CA) |
$105.4 million |
IPO |
|
Infectious diseases |
Private placement |
2017-05-30 |
Glycomimetics (USA - Md) |
$92.6 million |
private placement |
|
Cancer - Oncology |
Private placement |
2017-05-30 |
Albireo Pharma (USA - MA) |
$48.2 million |
private placement |
|
Gastrointestinal diseases - Digestive diseases - Liver diseases - Hepatic diseases |
Private placement |
2017-05-23 |
ArgenX (Belgium - The Netherlands) |
$114.7 million |
IPO |
|
|
IPO |
2017-05-16 |
Crispr Therapeutics (Switzerland - UK) |
|
grant |
Target ALS Foundation (USA) |
Neurodegenerative diseases |
Grant |
2017-05-16 |
Conatus Pharmaceuticals (USA - CA) |
$30.6 million |
private placement |
|
Hepatic diseases - Liver diseases |
Private placement |
2017-05-15 |
BiomX (Israel) |
€24 million |
series A financing round |
Johnson & Johnson Development Corporation (USA - NJ) Mirae Asset Global Investments (Republic of Korea) Orbimed (USA – NY) SBI (Japan) Seventure Partners (France) Takeda Ventures (Japan) |
|
Series A financing round |
2017-05-15 |
Mabvax Therapeutics (USA - CA) |
$4.1 million |
private placement |
|
|
Private placement |
2017-05-12 |
Theradiag (France) |
€4,023,994.90 |
capital increase |
|
|
Capital increase |
2017-05-12 |
Theradiag (France) |
€4 million |
capital increase |
|
Diagnostic - Autoimmune diseases - Immunological diseases |
Capital increase |
2017-05-10 |
Lonza (Switzerland) |
CHF 2.251 billion |
capital increase |
|
Technology - Services |
Capital increase |
2017-05-08 |
Argen-X (Belgium - The Netherlands) |
|
private placement |
|
|
Private placement |
2017-05-05 |
Amag Pharmaceuticals (USA - MA) |
|
private placement |
|
|
Private placement |
2017-05-05 |
Achaogen (USA - CA) |
up to $20.5 million |
grant |
Bill & Melinda Gates Foundation (USA) |
Infectious diseases |
Grant |
2017-05-04 |
Vivet Therapeutics (France) |
€37.5 million |
series A financing round |
Novartis Venture Fund (Switzerland) Columbus Venture Partners (Spain) Roche Venture Fund (Switzerland), HealthCap (Sweden) Kurma Partners (France) Ysios Capital (Spain) |
Rare diseases - Metabolic diseases |
Series A financing round |
2017-05-02 |
Noxxon Pharma (Germany) |
€ 11 million |
capital increase |
|
Cancer - Oncology |
Capital increase |
2017-05-02 |
Neurocrine Biosciences (US - CA) |
$502.2 million |
private placement |
|
Neurological diseases |
Private placement |